Thrombosis and cardiovascular risk in the elderly

R P Tracy1, E G Bovill

  • 1Department of Pathology, University of Vermont, Burlington.

Insights

Understanding thrombosis risk factors in the elderly is crucial for cardiovascular disease. Research is ongoing to clarify the roles of fibrinogen, Factor VII, and plasminogen activator inhibitor-1 in older adults.

Area of Science:

  • Cardiovascular Science
  • Thrombosis Research
  • Geriatric Medicine

Background:

  • Thrombosis plays a key role in cardiovascular disease (CVD) pathophysiology, precipitating clinical events and contributing to atherosclerosis.
  • Current understanding of thrombotic risk factors, particularly in the elderly population, remains limited.
  • While fibrinogen is an established risk factor in middle-aged adults, its role in older individuals is debated, and data on Factor VII and plasminogen activator inhibitor-1 in the elderly are lacking.

Purpose of the Study:

  • To highlight the current gaps in knowledge regarding thrombotic risk factors in the elderly.
  • To emphasize the need for further research into specific thrombotic factors like fibrinogen, Factor VII, and plasminogen activator inhibitor-1 in older populations.
  • To explore the complex interactions between thrombotic risk factors and other CVD risk factors in the elderly.

Main Methods:

  • Review of current literature on thrombosis and cardiovascular disease pathophysiology.
  • Identification of established and potential thrombotic risk factors.
  • Analysis of existing data and identification of research gaps, especially concerning the elderly.

Main Results:

  • Fibrinogen is a recognized independent risk factor in middle-aged individuals, but data for older adults are conflicting.
  • Factor VII and plasminogen activator inhibitor-1 show promise as risk factors in middle-aged individuals, with limited data in the elderly.
  • Complex associations exist between thrombotic factors and other CVD risk factors (lipids, glucose intolerance), complicating the establishment of independence, especially in older individuals.

Conclusions:

  • Further research is urgently needed to elucidate the role and independence of thrombotic risk factors in the elderly.
  • Understanding these factors and their interactions is critical for developing effective CVD prevention strategies in aging populations.
  • Ongoing studies are expected to provide significant insights into thrombotic risk in the elderly in the near future.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...